U.S. Markets open in 5 hrs 34 mins

InNexus Biotechnology, Inc. (IXSBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0001-0.0001 (-50.00%)
At close: 1:12PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) -114.58
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.0001
52 Week Low 30.0000
50-Day Moving Average 30.0000
200-Day Moving Average 30.0001

Share Statistics

Avg Vol (3 month) 33.13k
Avg Vol (10 day) 3N/A
Shares Outstanding 5154.19M
Implied Shares Outstanding 6N/A
Float N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Jun 29, 2010
Most Recent Quarter (mrq)Mar 30, 2011

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-30.74%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -1.37M
Net Income Avi to Common (ttm)-4.28M
Diluted EPS (ttm)-0.0250
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)31.43k
Total Cash Per Share (mrq)0
Total Debt (mrq)6.72M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.00
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-476.84k
Levered Free Cash Flow (ttm)-1.92M